Steris | STE - Operating Profit


Steris reported $285.8M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
3M USD 1.62B 64M Jun/2026
Accuray USD 4.71M 6.86M Dec/2024
Baxter International USD 276M 210M Jun/2026
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Boston Scientific USD 1.24B 190M Jun/2026
CONMED USD 36.4M 10.99M Jun/2026
Cooper Companies USD -31M 243.8M Mar/2026
Dexcom USD 318.3M 63M Jun/2026
Ecolab USD 809M 129.3M Jun/2026
Edwards Lifesciences USD 519.5M 4.8M Jun/2026
Fortive USD 209.9M 18.2M Jun/2026
Getinge SEK 1.35B 268M Jun/2026
Globus Medical USD -45.97M 209.97M Jun/2026
Haemonetics USD 57.46M 5.12M Jun/2026
Idexx Laboratories USD 425.57M 62.98M Jun/2026
Inogen USD -7.79M 728K Sep/2024
Insulet USD 129.7M 7.7M Jun/2026
Integra LifeSciences USD 41.29M 29.82M Jun/2026
Intuitive Surgical USD 977.6M 117.9M Jun/2026
J&J USD 7.48B 860M Jun/2026
Olympus JPY 30.07B 3.2B Jun/2026
Orthofix International USD 6.12M 1.91M Dec/2025
Owens Minor USD 814K 28.08M Dec/2025
ResMed USD 454.34M 51.33M Jun/2026
Steris USD 285.8M 32.9M Jun/2026
Stryker USD 1.79B 687M Jun/2026
Tandem Diabetes Care USD -13.79M 3.64M Jun/2026
Teleflex USD 73.07M 36.04M Jun/2026
Thermo Fisher Scientific USD 2.18B 273M Jun/2026
Zimmer Biomet Holdings USD 344.7M 50.4M Jun/2026